Subsequent negative feedback from mitophagy could regulate ROS levels and prevent further mitochondrial β-oxidation progression by restricting CPT1A, forcing acyl-CoA storage in LDs, ultimately promoting pazopanib resistance in ccRCC. This evidence concerns the gene CPT1A and nonpapillary renal cell carcinoma.